Phase II Study of Recombinant α-Interferon and Recombinant Interleukin-2 in Metastatic Breast Cancer

Ronald S. Walters; Richard L. Theriault; Frankie Ann Holmes; Laura Esparza; Gabriel N. Hortobagyi

doi:10.1097/00002371-199411000-00008

Phase II Study of Recombinant α-Interferon and Recombinant Interleukin-2 in Metastatic Breast Cancer

Ronald S. Walters
, Richard L. Theriault
, Frankie Ann Holmes
, Laura Esparza
, Gabriel N. Hortobagyi

Breast Medical Oncology

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Ten patients with metastatic breast cancer were treated with a combination of recombinant α-interferon and recombinant interleukin-2. The toxicity of treatment was considerable, including one death on therapy. No objective responses were seen.

Original language	English (US)
Pages (from-to)	303-305
Number of pages	3
Journal	Journal of Immunotherapy
Volume	16
Issue number	4
DOIs	https://doi.org/10.1097/00002371-199411000-00008
State	Published - Nov 1994

Keywords

Interferon
Interleukin-2
Metastatic breast cancer

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Pharmacology
Cancer Research

Access to Document

10.1097/00002371-199411000-00008

Cite this

@article{007192edc2ff426098a6ee2a119c1c6f,

title = "Phase II Study of Recombinant α-Interferon and Recombinant Interleukin-2 in Metastatic Breast Cancer",

abstract = "Ten patients with metastatic breast cancer were treated with a combination of recombinant α-interferon and recombinant interleukin-2. The toxicity of treatment was considerable, including one death on therapy. No objective responses were seen.",

keywords = "Interferon, Interleukin-2, Metastatic breast cancer",

author = "Walters, \{Ronald S.\} and Theriault, \{Richard L.\} and Holmes, \{Frankie Ann\} and Laura Esparza and Hortobagyi, \{Gabriel N.\}",

year = "1994",

month = nov,

doi = "10.1097/00002371-199411000-00008",

language = "English (US)",

volume = "16",

pages = "303--305",

journal = "Journal of Immunotherapy",

issn = "1524-9557",

publisher = "Lippincott Williams and Wilkins",

number = "4",

}

TY - JOUR

T1 - Phase II Study of Recombinant α-Interferon and Recombinant Interleukin-2 in Metastatic Breast Cancer

AU - Walters, Ronald S.

AU - Theriault, Richard L.

AU - Holmes, Frankie Ann

AU - Esparza, Laura

AU - Hortobagyi, Gabriel N.

PY - 1994/11

Y1 - 1994/11

N2 - Ten patients with metastatic breast cancer were treated with a combination of recombinant α-interferon and recombinant interleukin-2. The toxicity of treatment was considerable, including one death on therapy. No objective responses were seen.

AB - Ten patients with metastatic breast cancer were treated with a combination of recombinant α-interferon and recombinant interleukin-2. The toxicity of treatment was considerable, including one death on therapy. No objective responses were seen.

KW - Interferon

KW - Interleukin-2

KW - Metastatic breast cancer

UR - https://www.scopus.com/pages/publications/0028598875

UR - https://www.scopus.com/pages/publications/0028598875#tab=citedBy

U2 - 10.1097/00002371-199411000-00008

DO - 10.1097/00002371-199411000-00008

M3 - Article

C2 - 7881639

AN - SCOPUS:0028598875

SN - 1524-9557

VL - 16

SP - 303

EP - 305

JO - Journal of Immunotherapy

JF - Journal of Immunotherapy

IS - 4

ER -

Phase II Study of Recombinant α-Interferon and Recombinant Interleukin-2 in Metastatic Breast Cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this